Corporate Responsibility

Dr. Ron Jurgensen, Newport Beach Dentist Celebrates 30 Years of Humanitarian Service in Third-World Countries – Offering Hope Where there is None

October 13, 2017

Dr. Ron Jurgensen, Newport Beach Dentist Celebrates 30 Years of Humanitarian Service in Third-World Countries – Offering Hope Where there is None Every year for the past 30 years, Dr. Jurgensen has spent his vacations relieving the unimaginable suffering of impoverished people who have no access to dental care or hygiene. Newport Beach, Calif., October […]

CPhI Worldwide to support International Medical Corps UK with global charity partnership

October 9, 2017

Amsterdam, 4th October 2017: CPhI Worldwide, organised by UBM, announces a new dedicated charity partnership with International Medical Corps UK. Thecollaboration will see UBM extensively promote International Medical Corps across the global pharma community, with a range of fundraising and customised sponsorship packages. International Medical Corps UK was selected in light of its vital work in […]

HBAdvantage: Leadership in Action – Spring 2017

May 12, 2017

This year marks a special milestone for the Healthcare Businesswomen’s Association. Forty years ago, five courageous women  came together in New York with a shared passion to make the advertising and medical journal world of healthcare a place where women could not just survive but thrive. (Please turn to page 10 for more about the remarkable evolution/revolution of the HBA.) And since this […]

The Canadian Institute’s 3rd Annual Pharma Symposium

March 23, 2017

The Canadian Institute’s 3rd Annual Pharma Symposium The Road Ahead: From Clinical Trial to Market Access May 30-31, 2017 | One King West | Toronto Join us at The Canadian Institute’s 3rd Annual Pharma Symposium on May 30-31, 2017, where you’ll learn about the key issues facing the industry in today’s environment. Hear from a […]

Leveraging FDA’s Expedited Programs: Now and in the Future

March 14, 2017

FDA is committed to advancing the development of therapies that treat serious conditions and rare diseases. As part of this commitment, FDA offers expedited programs for biopharmaceutical companies to reduce development and review timelines for new drugs and biologics that address unmet medical needs. In this webinar, Cardinal Health regulatory experts will examine FDA’s four […]

Allergan Launches See America(SM), a Bold Initiative Furthering the Fight Against Preventable Blindness

February 9, 2017

DUBLIN, Feb. 7, 2017 /PRNewswire/ — Allergan plc (NYSE: AGN), a global leader in eye care for nearly 70 years, announces a bold commitment to fight preventable blindness in the United States with a new initiative—See America. Through See America, Allergan sets out to make vision health a priority for all Americans, increase awareness of the […]

Designing Effective Patient Assistance Programs (PAPs)

February 6, 2017

While economic reforms drive sweeping changes in healthcare, the reimbursement and access landscape for specialty drugs continues to grow more challenging. For patients facing serious illnesses and their healthcare providers, navigating the prior-authorization requirements and other barriers to care can be overwhelming. Many specialty drug manufacturers are taking steps to help patients overcome these access […]

An Advocacy Rx for Progress in Mental Health

January 31, 2017

Through sustained partnerships between advocacy and industry, the US and Europe can overcome barriers to care. As a source of human suffering, a barrier to workplace productivity, a burden on families and a driver of medical costs, mental illness amounts to an unparalleled public health crisis. Fortunately, there’s an abundance of smart thinking on how to improve the […]

Mental Health: Payer and Advocacy Perspectives in a Time of Policy Uncertainty

January 26, 2017

Heather Gartman discusses patient advocacy in the mental health space, including problem with underfunded research, the numerous stakeholders involved, and ways pharma and these stakeholders can come together to better support this extremely important area of the healthcare ecosystem. Also download our related white paper below, entitled, An Advocacy Rx for Progress in Mental Health.

Novartis highlights progress towards access and environmental goals in 2016 Corporate Responsibility Performance Report

January 26, 2017

Basel, January 26, 2017 – Novartis published its Corporate Responsibility (CR) Performance Report for the fourth consecutive year, highlighting progress on access and environmental goals in 2016. Building on the company’s long history of corporate responsibility and transparent reporting, the 2016 report provides even more context on the company’s CR performance across five key areas: […]

Inspiring Hope Ideathon

January 1, 2017

The Inspiring Hope Ideathon is a unique crowdsourcing event, which was co-hosted by INC Research, a global CRO committed to bringing innovation and value to customers, clinical research sites, and patients, and the nonprofit Center for Information and Study on Clinical Research Participation (CISCRP). The event brought together nearly 70 novel ideas to increase the […]

Octapharma donates Nuwiq® to the WFH Humanitarian Aid Program to provide patients with haemophilia A in developing countries access to therapy

December 27, 2016

LACHEN, Switzerland–(BUSINESS WIRE)–Octapharma is proud to announce that the company has made a charitable donation of 4.5 million units of its fourth generation, human cell-line derived recombinant factor VIII product, Nuwiq®, to the World Federation of Hematology (WFH) Humanitarian Aid Program. The lack of access to care in developing countries is an urgent and important […]

HBAdvantage: Achieving Gender Parity – Fall 2016

November 18, 2016

The Healthcare Businesswomen’s Association’s refreshed mission and subsequent strategic plan has been in place throughout 2016. As we move toward our goal of gender parity through gender partnership, we can look to current research to see where we are. We are working toward gender parity in leadership positions. We are partnering with organizations and companies that have parallel missions and vision. We are […]

Preparing for the Silver Tsunami: The Intersection of Healthcare and Technology

June 1, 2016

With more than 10,000 people a day turning 65 in the United States — equating to more than 2 billion seniors by 2050 — the healthcare industry needs to prepare to meet the demands of this older population. Patient care and technology are converging, and together they have the ability to improve the lives of […]

HBAdvantage: Transforming the Future – Spring 2016

April 28, 2016

Each May, for more than a quarter of a century, the HBA has filled the largest ballroom in New York City to celebrate extraordinary women leaders in the healthcare industry. Over the years, we’ve heard inspirational stories of leadership, transformation and innovation. This year, we thank those attending the Woman of the Year (WOTY) event in […]

HBAdvantage: Transforming the Future – March 2016

March 29, 2016

The HBA is embarking on a bold approach to transform the future of the healthcare industry: achieve gender parity. This issue of HBAdvantage focuses on numerous related issues. This pivot in direction first began in 2015 as the HBA’s board of directions re-evaluated the organization’s strategic plan based on feedback from key members of its advisory […]

How Pharma can turn the trend of the decade into a leadership advantage

March 1, 2016

The World Economic Forum has named collaboration as the key to global growth: public-private partnerships between companies large and small, NGOs, government agencies and academia are the single largest corporate trend of the decade. And why? The world’s problems are increasingly those that can only be solved by the best and brightest from a wide […]

Great Information on Rare Diseases and Orphan Drugs

February 8, 2016

If you work in the rare disease space, you will be very interested in this blog post. Publicis Touchpount Solutions recently published an outstanding white paper on rare diseases and orphan drugs. It’s packed with valuable statistics, research findings, images, and charts. Compared to most white papers, it’s a fairly deep dive, with 25 pages […]

Patients Defend Afrezza

January 13, 2016

Written by: Robin Robinson, Senior Editor, PharmaVOICE Magazine On Friday, Jan. 8, 2016, PharmaVOICE featured a news story quoting a third party in its This Week’s News In Review regarding Sanofi’s decision to dissolve the marketing partnership for Afrezza with MannKind. Readers in support of MannKind reached out to us to show their support for […]

HBAdvantage: Imagine What’s Possible

November 12, 2015

This HBAdvantage e-publication examines what’s possible when companies create a culture of inclusivity and meritocracy by including women on boards and in the C-suite, the impact a professional advocate can have on one’s career, what the future holds for the HBA, and a Q&A with a women of influence in the CRO sector. Some of […]

4 Ways Biopharma Can Build Trust and Loyalty: Patient Connections and Shared Values – A How-To Guide

September 8, 2015

This analysis of real-world examples and research shows the relationship between emotional connections, shared values and consumer behavior and discusses four ways biopharma companies can apply these elements to build brand loyalty. There is also a related podcast on this topic, which you can access through the link below.

4 Ways Biopharma Can Build Trust and Loyalty: Patient Connections and Shared Values – A Panel Discussion

September 8, 2015

In this episode, we’ll have a panel discussion with the heads of three of the four companies that make up the Health Perspectives Group, a family of companies that helps healthcare firms use shared values to infuse the patient perspective across their organizations to create a patient-centric culture from drug development through commercialization. If you […]

Leveraging Patient Feedback Data to Support Effectiveness and Demonstrate Outcomes

August 24, 2015

As the healthcare landscape moves increasingly toward outcome-based treatment approaches, the need to gather and analyze real-world outcome data has become paramount to gauging medication effectiveness and subsequently recruiting prescribers as brand advocates. This study outlines a feedback program that provides prescribers with patient results of their treatment experience in order to better inform their therapy recommendations. The program […]

Hiding in Plain Sight – Could Co-Pay Programs be the Solution for Better Outcomes?

August 17, 2015

The healthcare industry has been wringing its collective hands for years about the problems surrounding “patient engagement.” Beyond the fact that no one has a really good definition of what constitutes patient engagement, most everyone agrees that if you have more patient engagement, you’ll achieve better outcomes. Learn more about how co-pay programs lead to better outcomes.